AF solution
Oncology
Immuno Oncology
Anti-Virus
Disease Modeling
Cosmetics
Toxicity
Spatial Biology
Technology Service
Cancer Organoid
Research Service
Others
In the absence of predictive biomarkers and representative preclinical models for high-grade gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN), a fatal and heterogeneous malignancy, researchers established patient-derived (PD) tumoroids from biobanked tissue samples. This model facilitated rapid ex vivo pharmacotyping, next-generation sequencing, and perturbational profiling. PD tumoroids accurately mirrored biological features of high-grade GEP-NEN and replicated clinical responses to cisplatin and temozolomide. Investigation of treatment-induced adaptive stress responses identified synergistic effects of Lysine demethylase 5 A and interferon-beta with cisplatin. Notably, ex vivo drug response correlated with patients’ clinical responses, suggesting potential for personalized therapeutic options for advanced high-grade GEP-NEN.
Keywords: Organoids, tumoroids, neuroendocrine, personalized therapy, neoplasms
@ 2024 . All rights reserved
@ 2024 . All rights reserved
Log in to MyLab and
download your gift voucher from the ‘Vouchers’ menu!
Thank you for your continued trust and partnership.
We look forward to serving you with excellence.